NEW YORK, March 2, 2023 /PRNewswire/ — The biologics CDMO market is estimated to accelerate at a CAGR of 13.97% and register an incremental growth of USD 13.26 billion during the forecast period. The strong research and development pipeline of biologics therapeutics is driving the market…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.